Sepsis and Scientific Revolutions

被引:34
作者
Artenstein, Andrew W. [1 ,2 ]
Higgins, Thomas L. [1 ,2 ]
Opal, Steven M. [3 ,4 ]
机构
[1] Baystate Hlth, Dept Med, Springfield, MA 01199 USA
[2] Tufts Univ, Sch Med, Springfield, MA 01199 USA
[3] Mem Hosp Rhode Isl, Div Infect Dis, Providence, RI USA
[4] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
关键词
paradigm shift; sepsis; therapeutic revolution; SURVIVING SEPSIS; MODEL;
D O I
10.1097/CCM.0b013e31829eb98f
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Hypothesis: The therapeutic approach to sepsis is following an evolutionary process of scientific discovery as articulated in the landmark work by Kuhn, The Structure of Scientific Revolutions, first published 50 years ago. Background: Incremental advances, beginning with the introduction of antimicrobials and most recently highlighted by revised, evidence-based guidelines for the management of sepsis, have been accompanied by episodic paradigm shifts. Although some of these have shown success, there are numerous, noteworthy failures, largely involving immune- and coagulation-based therapeutic strategies. Conclusion: A sustained paradigm shift in the approach to treating sepsis has yet to emerge, but recent data suggest that an open-minded posture informed by novel pathobiologic findings may eventually bear fruit.
引用
收藏
页码:2770 / 2772
页数:3
相关论文
共 14 条
  • [1] Sir Isaac Newton, sepsis, SIRS, and CARS
    Bone, RC
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (07) : 1125 - 1128
  • [2] Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6
  • [3] Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis
    Cavaillon, Jean-Marc
    Adib-Conquy, Minou
    [J]. CRITICAL CARE, 2006, 10 (05):
  • [4] Sepsis studies need new direction
    Cohen, Jonathan
    Opal, Steven
    Calandra, Thierry
    [J]. LANCET INFECTIOUS DISEASES, 2012, 12 (07) : 503 - 505
  • [5] Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
    Dellinger, R. Phillip
    Levy, Mitchell M.
    Rhodes, Andrew
    Annane, Djillali
    Gerlach, Herwig
    Opal, Steven M.
    Sevransky, Jonathan E.
    Sprung, Charles L.
    Douglas, Ivor S.
    Jaeschke, Roman
    Osborn, Tiffany M.
    Nunnally, Mark E.
    Townsend, Sean R.
    Reinhart, Konrad
    Kleinpell, Ruth M.
    Angus, Derek C.
    Deutschman, Clifford S.
    Machado, Flavia R.
    Rubenfeld, Gordon D.
    Webb, Steven A.
    Beale, Richard J.
    Vincent, Jean-Louis
    Moreno, Rui
    Aitken, Leanne
    Al Rahma, Hussain
    Annane, Dijillali
    Bernard, Gordon R.
    Biban, Paolo
    Bion, Julian F.
    Calandra, Thierry
    Carcillo, Joseph A.
    Clemmer, Terry P.
    Divatia, J. V.
    Du, Bin
    Fujishima, Seitaro
    Gando, Satoshi
    Goodyear-Bruch, Caryl
    Guyatt, Gordon
    Hazelzet, Jan A.
    Hirasawa, Hiroyuki
    Hollenberg, Steven M.
    Jacobi, Judith
    Jenkins, Ian
    Jimenez, Edgar
    Jones, Alan E.
    Kacmarek, Robert M.
    Kern, Winfried
    Koh, Shin Ok
    Kotani, Joji
    Levy, Mitchell
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (02) : 580 - 637
  • [6] Gene-specific control of inflammation by TLR-induced chromatin modifications
    Foster, Simmie L.
    Hargreaves, Diana C.
    Medzhitov, Ruslan
    [J]. NATURE, 2007, 447 (7147) : 972 - U4
  • [7] Immunotherapy for Sepsis - A New Approach against an Ancient Foe
    Hotchkiss, Richard S.
    Opal, Steven
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) : 87 - 89
  • [8] Medical progress: The pathophysiology and treatment of sepsis.
    Hotchkiss, RS
    Karl, IE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02) : 138 - 150
  • [9] THE IMMUNE-SYSTEM EVOLVED TO DISCRIMINATE INFECTIOUS NONSELF FROM NONINFECTIOUS SELF
    JANEWAY, CA
    [J]. IMMUNOLOGY TODAY, 1992, 13 (01): : 11 - 16
  • [10] Kuhn T. S., 1962, STRUCTURE SCI REVOLU